Compare ENOV & NRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENOV | NRK |
|---|---|---|
| Founded | 1995 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Trusts Except Educational Religious and Charitable |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 814.8M |
| IPO Year | 2008 | 2002 |
| Metric | ENOV | NRK |
|---|---|---|
| Price | $20.88 | $9.59 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $36.08 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 507.9K |
| Earning Date | 11-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.05 | N/A |
| Revenue Next Year | $4.89 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.70 | $9.01 |
| 52 Week High | $32.41 | $10.90 |
| Indicator | ENOV | NRK |
|---|---|---|
| Relative Strength Index (RSI) | 51.81 | 56.91 |
| Support Level | $19.14 | $9.02 |
| Resistance Level | $27.20 | $10.61 |
| Average True Range (ATR) | 1.01 | 0.14 |
| MACD | 0.16 | 0.07 |
| Stochastic Oscillator | 50.16 | 85.47 |
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
Nuveen New York AMT-Free Quality Municipal Income Fund is a closed-end investment company. The Fund seeks to provide current income exempt from regular federal, New York State, and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.